Search Results
Dr. David Steensma shares findings from the H3B-8800 clinical trial for myeloid malignancies
Conversations with Innovators: David Steensma, MD
David Steensma, MD, on Treatment Options for Myelodysplastic Syndromes
THE CANCER QUESTIONS PROJECT: David Steensma, M.D.
Dr. David Steensma on MDS research | Dana-Farber Cancer Institute
Dr. David Steensma on Myelodysplastic Syndrome
ASH Impact Series: David Steensma, MD - Examining Current Research Initiatives in MDS
MCP 60 Seconds With Dr. David Steensma on Clonal Hematopoiesis
Comments from a patient of Dr. Steensma - Thanks Doris
Dr. Matt Steensma
What are the main treatment options for AML? What are the goals of each treatment?
Myeloid neoplasms - AML, MDS, CML, MPNs
